ArticleClinical optometry2025
Assessment of Visual Function Using Yellow-Tinted Filter in Patients with Pre-Perimetric and Early Open Angle Glaucoma.
Article in Clinical optometry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to assess the effect of an external yellow-tinted filter (KIROS 1-400 lens) on visual function in patients with pre-perimetric glaucoma (PPG) and early primary open-angle glaucoma (POAG). The primary outcomes were contrast sensitivity (CS) and visual field (VF) indices assessed using standard automated perimetry (SAP). Methods: This comparative observational, within-subject study included 30 patients with PPG (30 eyes) and 50 with POAG (50 eyes) recruited from the Ophthalmology Department of the 401 General Military Hospital, Athens, between January and December 2022. CS was measured using the Pelli-Robson chart. VF indices, including mean deviation (MD), pattern standard deviation (PSD), visual field index (VFI), and Glaucoma Hemifield Test (GHT) classifications, were assessed with SAP with the 24-2 SITA-standard strategy on the Humphrey Field Analyzer II 740. All testing was performed both with and without the yellow filter KIROS 1-400 (Essilor International) in the same eyes. Results: The KIROS 1-400 filter significantly enhanced CS in both PPG and POAG eyes, increasing the median logCS by 0.03. However, while statistically significant, this improvement may not be clinically meaningful. In contrast, no significant changes were observed in the VF indices (MD, PSD, and VFI) when the filter was applied. Analysis of GHT results revealed that the filter reduced borderline classifications and showed high precision (0.733) and recall (0.846) for "outside normal limits" classifications. However, the agreement between the filtered and unfiltered GHT results was fair. Conclusion: The KIROS 1-400 filter significantly enhanced CS in patients with PPG and POAG without notable effects on the VF indices. However, caution is advised when interpreting GHT results obtained with yellow-tinted filters. Further studies are recommended to evaluate the filter's long-term clinical benefits and its potential role in glaucoma management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.